NASDAQ
CytoMed Therapeutics Limited (GDTC) has a interest coverage ratio of -219.72x as of Friday, May 29, 2026. This represents a 201.77% decrease compared to its 12-month average of -72.81x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.